• Online Features  This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Medical Practice  • Conflict of Interest  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Eric G. Campbell, PhD; Sowmya R. Rao, PhD; Catherine M. DesRoches, DrPh; Lisa I. Iezzoni, MD; Christine Vogeli, PhD; Dragana Bolcic-Jankovic, MA; Paola D. Miralles, BS

Arch Intern Med. 2010;170(20):1820-1826. doi:10.1001/archinternmed.2010.383

Background  One tenet of medical professionalism is managing conflicts of interest related to physician-industry relationships (PIRs). Since 2004 much has been done at the institutional, state, and national levels to limit PIRs. This study estimates the nature, extent, consequences, and changes in PIRs nationally.

Methods  We performed a national survey of a stratified random sample of 2938 primary care physicians (internal medicine, family practice, and pediatrics) and specialists (cardiology, general surgery, psychiatry, and anesthesiology). A total of 1891 physicians completed the survey, yielding an overall response rate of 64.4%. The main outcome measure was prevalence of several types of PIRs and comparison with PIRs in 2004.

Results  Overall, 83.8% of all respondents reported some type of relationship with industry during the previous year. Approximately two-thirds (63.8%) received drug samples, 70.6% food and beverages, 18.3% reimbursements, and 14.1% payments for professional services. Since 2004 the percentage of each of these benefits has decreased significantly. Higher rates of PIRs are significantly and inversely associated with low levels of Medicare spending.

Conclusion  Among a random sample of physicians, the prevalence of self-reported PIRs in 2009 was 83.8%, which was lower than in 2004.

Author Affiliations: Mongan Institute for Health Policy at Massachusetts General Hospital (Drs Campbell, Rao, DesRoches, Iezzoni, and Vogeli and Ms Miralles), Center for Survey Research, University of Massachusetts at Boston (Ms Bolcic-Jankovic), and Harvard Medical School (Drs Campbell, Rao, DesRoches, Iezzoni, and Vogeli), Boston.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Does family medicine have a professional obligation to play a leading role in pharmaceutical industry-sponsored drug research?: YES
D'Urzo
cfp 2011;57:870-872.
FULL TEXT  

La medecine familiale a-t-elle une obligation professionnelle de jouer un role preponderant dans la recherche sur les medicaments financee par l'industrie pharmaceutique?: OUI
D'Urzo
cfp 2011;57:874-876.
FULL TEXT  

Physician Relationships with the Healthcare Industry
JWatch General 2010;2010:3-3.
FULL TEXT